BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://www.med.unc.edu/medicine X-WR-CALDESC:Events for Department of Medicine REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20170312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20171105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20180311T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20181104T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20190310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20191103T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20180503T120000 DTEND;TZID=America/New_York:20180503T130000 DTSTAMP:20260617T190345 CREATED:20180503T160000Z LAST-MODIFIED:20190307T184254Z UID:10000877-1525348800-1525352400@www.med.unc.edu SUMMARY:Medicine Grand Rounds Blythe Lecture\, Mark Zeidel "Salt and Water\, Not So Simple" DESCRIPTION:Dr. Blythe was an expert in salt and water homeostasis. This lecture will use a case-based approach to review the overall principles of salt and water homeostasis\, and will describe new paradigms in long term salt balance\, the storage of salt in the tissues and the neural control of salt appetite and thirst. Future advances in salt and water homeostasis will enhance the therapy of hypertension and shock\, as well as disorders of water metabolism. \nDr. Mark Zeidel is Herrman L. Blumgart Professor of Medicine at Harvard Medical School\, and Chair and Physician-in-Chief at Beth Israel Deaconess Medical Center in Boston. His research has been recognized by the American Physiological Society\, the American Society for Clinical Investigation and the Association of American Physicians. His research has received continuous funding by the NIH for more than 30 years. \nEvery one to three years\, the Division of Nephrology and Kidney Center invites a lecturer to honor the memory of Dr. William Blythe\, II. Dr. Blythe\, the first Division Chief for Nephrology and Hypertension at UNC\, was an outstanding physician-scientist and teacher who inspired many of us to pursue nephrology. He was also a gifted man of letters. URL:https://www.med.unc.edu/medicine/event/may-3/ CATEGORIES:Medicine Grand Rounds ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/mark-zeidel.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20180507T120000 DTEND;TZID=America/New_York:20180507T130000 DTSTAMP:20260617T190345 CREATED:20180507T160000Z LAST-MODIFIED:20190307T184251Z UID:10000879-1525694400-1525698000@www.med.unc.edu SUMMARY:Cardiovascular Grand Rounds: Olga Bokeriya\, MD\, PhD\, FACC\, "The Russian National Center for Cardiology and Cardiovascular Surgery: Extensive Experience and Creative Innovations" DESCRIPTION:Speaker: Olga Bokeriya\, MD\, PhD\, FACC\, Professor of Cardiology; Chief\, Department of Cardiac Surgery; Chief Scientist and Physician for Bakoulev National Medical and Research Center for Cardiovascular Surgery and Ministry for Healthcare\, Russian Federation in MoscowTopic: “The Russian National Center for Cardiology and Cardiovascular Surgery: Extensive Experience and Creative Innovations” URL:https://www.med.unc.edu/medicine/event/cardiovascular-grand-rounds-olga-bokeriya-md-phd-facc-the-russian-national-center-for-cardiology-and-cardiovascular-surgery-extensive-experience-and-creative-innovations/ CATEGORIES:Medicine Grand Rounds END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20180510T120000 DTEND;TZID=America/New_York:20180510T130000 DTSTAMP:20260617T190345 CREATED:20180510T160000Z LAST-MODIFIED:20190307T184249Z UID:10000880-1525953600-1525957200@www.med.unc.edu SUMMARY:Medicine Grand Rounds\, Steven Russell "The Bionic Pancreas" DESCRIPTION:The bionic pancreas system proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home\, with no restrictions\, over 11 days. “For study participants living at home without limitations on their activity and diet\, the bionic pancreas successfully reduced average blood glucose\, while at the same time decreasing the risk of hypoglycemia\,” says Steven Russell. “This system requires no information other than the patient’s body weight to start\, so it will require much less time and effort by health care providers to initiate treatment. And since no carbohydrate counting is required\, it significantly reduces the burden on patients associated with diabetes management.” \nSince 2006 Steven Russell has collaborated on this project with Dr. Edward Damiano\, a Biomedical Engineer at Boston University. The trials are scheduled to begin in the fourth quarter of 2018. URL:https://www.med.unc.edu/medicine/event/may-10/ CATEGORIES:Medicine Grand Rounds ATTACH;FMTTYPE=image/png:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/steven-russell.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20180517T120000 DTEND;TZID=America/New_York:20180517T130000 DTSTAMP:20260617T190345 CREATED:20180517T160000Z LAST-MODIFIED:20190307T184247Z UID:10000882-1526558400-1526562000@www.med.unc.edu SUMMARY:Medicine Grand Rounds\, Sascha Tuchman and Koyal Jain\, "Amyloidosis\, Cyanide\, Myeloma and Ethanol: Conceptualizing Renal Diseases Caused by Monoclonal Gammopathies" DESCRIPTION:Monoclonal gammopathies are a group of plasma cell or B-cell disorders including true cancers such as multiple myeloma or “sort-of cancers” such as light chain amyloidosis. These disorders in many cases cause no injury to a person (i.e.\, monoclonal gammopathy of undetermined significance [MGUS]) but when they do cause injury\, the pattern of injury can be quite varied and often includes the kidneys. Monoclonal gammopathy of renal significance (MGRS) is a recently described category of nephrotroxic monoclonal gammopathies that arise in the absence of an overt hematologic malignancy. Monoclonal gammopathies overall have been increasingly recognized as a cause of renal failure. Over 660\,000 Americans have kidney failure\, and early recognition of the etiology of kidney disease can prevent progression to end-stage kidney disease through aggressive interventions\, such as chemotherapy in proven cases of multiple myeloma or MGRS. The management of these patients requires close collaboration between nephrologists and oncologists. In this presentation\, we will be focusing on the wide spectrum of diseases associated with nephrotoxic plasma cell disorders\, with a focus on how to conceptualize them clinically. \nSascha Tuchman is a UNC Comprehensive Cancer Center member and Associate Professor of Medicine. Dr. Tuchman’s research has a special focus on amyloidosis and multiple myeloma. \nKoyal Jain is an Assistant Professor of Medicine in the Nephrology division. She specializes in acute kidney injury and chronic kidney disease\, dialysis management\, high blood pressure management\, abnormalities of electrolytes like sodium\, potassium\, calcium\, and glomerular diseases. URL:https://www.med.unc.edu/medicine/event/may-17/ CATEGORIES:Medicine Grand Rounds ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/sascha-tuchman.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20180522T140000 DTEND;TZID=America/New_York:20180522T150000 DTSTAMP:20260617T190345 CREATED:20180522T180000Z LAST-MODIFIED:20190307T184245Z UID:10000884-1526997600-1527001200@www.med.unc.edu SUMMARY:McAllister Heart Institute Seminar Series: David Zawieja\, PhD\, "Lymphatics: the link between the parenchyma\, cardiovascular and immune systems" DESCRIPTION:Speaker: David Zawieja\, PhD\, Regents Professor and Department Head of Medical Physiology\, Texas A&M University College of MedicineTopic: Lymphatics: the link between the parenchyma\, cardiovascular and immune systems URL:https://www.med.unc.edu/medicine/event/mcallister-heart-institute-seminar-series-david-zawieja-phd-lymphatics-the-link-between-the-parenchyma-cardiovascular-and-immune-systems/ CATEGORIES:Medicine Grand Rounds END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20180524T120000 DTEND;TZID=America/New_York:20180524T130000 DTSTAMP:20260617T190345 CREATED:20180524T160000Z LAST-MODIFIED:20190327T143003Z UID:10000996-1527163200-1527166800@www.med.unc.edu SUMMARY:Medicine Grand Rounds\, Tony Mazzella\, Rosanne Tiller\, Russell Coletti\, and Alyssa Tilly\, "Chief Resident Year in Review" DESCRIPTION:Tony Mazzella and Rosanne Tiller will present Multidisciplinary Bedside Rounds\, their project to restructure rounds with a consistent multidisciplinary team presence at the patients’ bedsides to have a clinical discussion with the most important team member: the patient. \nAlyssa Tilly will discuss the Professional Development Coaching Program\, a modality to promote resilience and combat burnout by allowing those who are being coached to self-identify positive individual traits and experiences. \nRussell Coletti will present Expected Practices Tool\, a quality improvement measure to enhance the initial care of patients with Rheumatoid Arthritis. This tool can be expanded to other medical conditions\, improving patient care by fostering collaboration between primary care and specialty practices. URL:https://www.med.unc.edu/medicine/event/may-24/ CATEGORIES:Medicine Grand Rounds ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2019/01/2018-Chief-Residents.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20180531T120000 DTEND;TZID=America/New_York:20180531T130000 DTSTAMP:20260617T190345 CREATED:20180531T160000Z LAST-MODIFIED:20190307T184241Z UID:10000997-1527768000-1527771600@www.med.unc.edu SUMMARY:Medicine Grand Rounds\, Saira Sheikh “BAFFling New Lupus Therapies – Looking to the Future After Decades of Failed Clinical Trials” DESCRIPTION:Systemic lupus erythematosus (SLE) is a chronic\, debilitating autoimmune disease with heterogeneous manifestations ranging from scarring skin rash or arthritis to severe\, organ-threatening involvement of the kidneys\, heart\, lungs or central nervous system. SLE is characterized by the presence of autoantibodies against nuclear antigens\, which are thought to be caused by dysregulation of the immune system. Development of new therapies is critical due to unmet needs associated with SLE\, including inadequate disease control\, poor health-related quality of life\, medication toxicities and increased morbidity and mortality. \nOne challenge in caring for patients with SLE is a lack of approved and efficacious medications. Randomized controlled trials evaluating novel biologic immune modulators in SLE have been largely unsuccessful at achieving the primary endpoints needed for FDA approval. Efforts to develop therapies against specific molecular targets in SLE has resulted in the identification of BAFF (B-cell activating factor) inhibitors to treat the disease. This talk will provide a summary of that journey and a brief overview of what’s on the horizon for SLE therapies. \nDr. Saira Sheikh is an Assistant Professor of Medicine\, Director of Clinical Trials Program at the UNC Thurston Arthritis Research Center and Director of the UNC Rheumatology Lupus Clinic. Dr. Sheikh’s work has been focused on building a Collaborative Lupus Clinical & Research Program that directly impacts the care of patients. She is working on a national level to develop programs that address racial disparities in lupus clinical trials. URL:https://www.med.unc.edu/medicine/event/may-31/ CATEGORIES:Medicine Grand Rounds ATTACH;FMTTYPE=image/png:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/saira-sheikh.png END:VEVENT END:VCALENDAR